Page last updated: 2024-11-08
biguanides and Deafness
biguanides has been researched along with Deafness in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Deafness: A general term for the complete loss of the ability to hear from both ears.
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Løokken, P | 1 |
| Borchegrevink, CF | 1 |
| Bicknell, PG | 1 |
Other Studies
2 other studies available for biguanides and Deafness
| Article | Year |
|---|---|
[From the Adverse Drug Reaction Committee. Chlorhexidine--toxicity--ototoxicity].
Topics: Biguanides; Chlorhexidine; Deafness; Humans | 1976 |
Sensorineural deafness following myringoplasty operations.
Topics: Adolescent; Adult; Audiometry; Biguanides; Bone Conduction; Deafness; Female; Humans; Male; Middle A | 1971 |